Universe Pharmaceuticals UPC
NASDAQ UPC
$5.33 -0.01 (-0.19%)
At close: Aug 20, 2026 · 4:00 PM EDT

Universe Pharmaceuticals (UPC) Common Equity (2020 - 2026)

Universe Pharmaceuticals (UPC) posted Common Equity of $55.6 million for Q1 2026, down 0.86% sequentially from $56.1 million in Q3 2025.

Universe Pharmaceuticals (UPC) Common Equity (2020 - 2026) Analysis & Trends

Universe Pharmaceuticals has reported Common Equity for 7 years, with the latest figure at $55.6 million in Q1 2026.

  • Quarterly Common Equity changed N/A year-over-year to $55.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.6 million (changed N/A YoY) and the FY2025 annual result came in at $56.1 million, up 23.35% from the prior year.
  • Common Equity fell to $55.6 million in Q1 2026 per UPC's latest filing, from $56.1 million in the prior quarter.
  • Over five years, Common Equity peaked at $35.3 billion in Q3 2022 and troughed at $26.7 million in Q1 2024.
  • A 5-year average of $7.9 billion and a median of $55.9 million in 2025 frame the typical range for Common Equity.
  • The sharpest annual moves came in 2022 and 2024: Common Equity surged 75083.64% in 2022, then tumbled 99.84% in 2024.
  • Over 5 years, Common Equity stood at $35.3 billion in 2022, then dropped by 20.83% to $28.0 billion in 2023, then sank by 99.84% to $45.5 million in 2024, then grew by 23.35% to $56.1 million in 2025, then slipped by 0.86% to $55.6 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $55.6 million, $56.1 million, and $45.5 million for Q1 2026, Q3 2025, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 22.06 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 7.76 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 3.15 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 47.42 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 6.40 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 14.26 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 3.69 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 6.59 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 4.05 Bn
10 Universe Pharmaceuticals 3.04 Mn -26.01 Mn - 55.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 55.65 Mn
Sep 30, 2025 56.13 Mn
Sep 30, 2024 45.50 Mn
Mar 31, 2024 26.74 Mn
Sep 30, 2023 27.97 Bn
Mar 31, 2023 47.13 Mn
Sep 30, 2022 35.33 Bn
Mar 31, 2022 61.16 Mn
Sep 30, 2021 46.99 Mn
Sep 30, 2020 20.80 Mn